EMFLAZA

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 52856-501
  • Package NDC 52856-501-01
  • Application number NDA208684
  • SPL ID 2b07ec82-2eb4-4a87-9787-9c2db6a0649b
  • SPL set ID 31b347d2-f156-4055-9d8f-7cf0df420296
  • UNII KR5YZ6AE4B
  • RxCUI 153098
  • RxCUI 153880
  • RxCUI 1870950
  • RxCUI 1870952
  • RxCUI 1870954
  • RxCUI 1870956
  • RxCUI 1870958
  • RxCUI 1870960
  • RxCUI 1870964
  • RxCUI 1870968

What the source publishes

Labeler
PTC Therapeutics, Inc.
Active ingredients
deflazacort
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:52856-501_2b07ec82-2eb4-4a87-9787-9c2db6a0649b
{
  "name": "EMFLAZA",
  "splId": "2b07ec82-2eb4-4a87-9787-9c2db6a0649b",
  "labels": [
    {
      "setId": "31b347d2-f156-4055-9d8f-7cf0df420296",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31b347d2-f156-4055-9d8f-7cf0df420296",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=31b347d2-f156-4055-9d8f-7cf0df420296"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "PTC Therapeutics, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 TABLET in 1 BOTTLE (52856-501-01)",
      "package_ndc": "52856-501-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20180910"
    }
  ],
  "productId": "52856-501_2b07ec82-2eb4-4a87-9787-9c2db6a0649b",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "52856-501",
  "deaSchedule": null,
  "genericName": "deflazacort",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "DEFLAZACORT",
      "strength": "6 mg/1"
    }
  ],
  "applicationNumber": "NDA208684",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20180910",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175576",
      "N0000175450"
    ],
    "unii": [
      "KR5YZ6AE4B"
    ],
    "rxcui": [
      "153098",
      "153880",
      "1870950",
      "1870952",
      "1870954",
      "1870956",
      "1870958",
      "1870960",
      "1870964",
      "1870968"
    ],
    "spl_set_id": [
      "31b347d2-f156-4055-9d8f-7cf0df420296"
    ],
    "pharm_class_epc": [
      "Corticosteroid [EPC]"
    ],
    "pharm_class_moa": [
      "Corticosteroid Hormone Receptor Agonists [MoA]"
    ],
    "manufacturer_name": [
      "PTC Therapeutics, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:52856-501_2b07ec82-2eb4-4a87-9787-9c2db6a0649b"